Han Kun advised Shanghai Sinopharm Equity Investment Fund on Pre-IPO investment in Anhui Shilian Special Solvent Corporation
2013-09-11
Han Kun recently advised Shanghai Sinopharm Equity Investment Fund on its pre-IPO investment in Anhui Shilian Special Solvent Corporation, a solvent producer purporting to list on domestic main board. Han Kun team has fully involved in the investment, including conducting legal due diligence on the target company, carrying on negotiations and preparing a full set of transactional documents.
Evan Zhang, Yinshi Cao, Maggie Tan, Feiya Wang and Xinfeng Zhang worked on this transaction.